Dr. Bui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-456-2382Fax+1 214-456-6133
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2018 - 2021
- University of Texas at Austin Dell Medical SchoolResidency, Pediatrics, 2015 - 2018
- Texas A&M; Health Science Center College of MedicineClass of 2015
Certifications & Licensure
- TX State Medical License 2017 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling Start of enrollment: 2022 Feb 24
- Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG Start of enrollment: 2023 Oct 01
Publications & Presentations
PubMed
- The role of MEK inhibition in pediatric low-grade gliomas.Shehryar R Sheikh, Laura J Klesse, Ross Mangum, Ashley Bui, Benjamin I Siegel
Frontiers in Oncology. 2024-01-01 - 12 citationsTargeted Therapies for the NeurofibromatosesLauren D. Sanchez, Ashley Bui, Laura J. Klesse
Cancers. 2021-11-30 - 5 citationsInsights into the Pathogenesis of NF1-Associated Neoplasms.Ashley Bui, Chunhui Jiang, Renée M. McKay, Laura J. Klesse, Lu Q. Le
JID Innovations. 2021-08-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: